Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
clinical trials
life sciences
national blog main
amgen
boston blog main
cholesterol
inclisiran
new york
new york blog main
new york top stories
regeneron pharmaceuticals
alnylam pharmaceuticals
biotech
boston top stories
national top stories
pcsk9 inhibitors
praluent
repatha
the medicines co.
alirocumab
bempedoic acid
corticosteroids
data
detroit
detroit blog main
detroit top stories
drugs
esperion therapeutics
evercore isi
evolocumab
ezetimibe
fda
fluoroquinolones
heart attack
joseph swartz
ldl
mark timney
medicines co.
mt sinai hospital
pcsk9
What
cholesterol
drug
5
×
lowering
5
×
medicines
5
×
fda
medco
heart
new
twice
aces
administration
advisory
alnylam
announced
approval
approved
approving
attacks
based
big
bringing
cardiovascular
ceo
clears
closer
combo
data
dramatically
esperion
esperion’s
evidence
favor
filing
flexible
food
greatly
health
help
inched
inclisiran
Language
unset
Current search:
drug
×
medicines
×
lowering
×
@xconomy.com
4 years ago
Esperion’s Combo Pill for Lowering Cholesterol Levels Wins FDA Nod
@xconomy.com
4 years ago
MedCo Preps for FDA Filing as Cholesterol Drug Clears Last Two Tests
@xconomy.com
4 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing
@xconomy.com
4 years ago
MedCo Touts New Data for Long-Lasting Heart Drug as Reckoning Looms
@theverge.com
8 years ago
FDA panel recommends approving new drug that dramatically lowers cholesterol